CELESTIAL THERAPEUTICS INC
Irvine, CA · Founded 2019 · CIK 0001804448 · Biotech · Private
Novel therapeutic molecules and biologics for infectious diseases, rare diseases, and cancers
celestialtherapeutics.com →- Grants
- $1.6M
- 3 awards
- Sector median: 1
- Raised
- $125K
- 2 Form D · Sep 2024
- 25 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 0 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $25,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Development of a dry powder inhalation product against Respiratory Syncytial Virus based on an endogenous anionic pulmonary surfactant lipid | $290,117 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of a dry powder inhalation product against Respiratory Syncytial Virus based on an endogenous anionic pulmonary surfactant lipid | $290,117 | |
| Private capital raised | Form D · SEC | $100,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a dry powder inhalation product against Respiratory Syncytial Virus based on an endogenous anionic pulmonary surfactant lipid | $1,000,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1915 | RIPARIAN PHARMACEUTICALS INC | — | $500K |
| 1916 | Origin Protocol, Inc. | — | $38M |
| 1917 | NGM Bio Holdings, Inc. | — | $73M |
| 1918 | CELESTIAL THERAPEUTICS INC | — | $125K |
| 1919 | CAMBRIDGE TECHNOLOGIES LLC | — | $3.5M |
| 1920 | ONCOTHERAPY SOLUTIONS, LLC | — | — |
| 1921 | WILD MICROBES CO | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Annelise BarronDirector
- ANNELISE BARRONDirector
- JOHN FORTKORTExecutive Officer
- Ajay GuptaDirector · Executive Officer
- AJAY GUPTADirector · Executive Officer
- George SiberDirector
- Leontis TeryazosDirector · Executive Officer
- LEONTIS TERYAZOSDirector · Executive Officer
Patents
- Phospholipid Compositions For Treating Infections And Inflammationapplication
- SELECTIVE AGONISM OF SPECIFIC PATTERN RECOGNITION RECEPTORS IN mRNA CONSTRUCTS FOR SAFE, EFFECTIVE AND DURABLE VACCINESapplication
- Method For Generating Dry Powder Suitable For Inhalation Administration Of Antimicrobial Phospholipid Compositionsapplication
- Methods Of Preparation Of Novel Pan Tlr Antagonistic Liposomal-lnp Formulations And Uses Thereofapplication
- Phospholipid Compositions For Treating Infections And Inflammationapplication
- Methods Of Preparation Of Novel Pan Tlr Antagonistic Liposomal-lnp Formulations And Uses Thereofapplication
- Selective Agonism Of Specific Pattern Recognition Receptors In Self-adjuvanting Mrna Constructs As A Way Of Generating Safe, Effective And Durable Vaccines & Therapeuticsapplication
- Method For Generating Dry Powder Suitable For Inhalation/intranasal/intratracheal Administration Of Antimicrobial Phospholipid Compositionsapplication
- Phospholipid Compositions For Treating Infections And Inflammationapplication
- SELECTIVE AGONISM OF SPECIFIC PATTERN RECOGNITION RECEPTORS IN SELF-ADJUVANTING mRNA CONSTRUCTS AS A WAY OF GENERATING SAFE, EFFECTIVE AND DURABLE VACCINESapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.